RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 34 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,877 | -7.0% | 4,580 | -19.9% | 0.00% | – |
| Q2 2023 | $37,491 | +396.0% | 5,715 | +352.1% | 0.00% | – |
| Q1 2023 | $7,559 | +156.8% | 1,264 | +0.1% | 0.00% | – |
| Q4 2022 | $2,943 | -26.4% | 1,263 | +0.1% | 0.00% | – |
| Q3 2022 | $4,000 | +33.3% | 1,262 | +1.5% | 0.00% | – |
| Q2 2022 | $3,000 | -81.2% | 1,243 | -76.8% | 0.00% | – |
| Q1 2022 | $16,000 | -76.5% | 5,364 | -32.8% | 0.00% | – |
| Q4 2021 | $68,000 | – | 7,979 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
| Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
| Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
| NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
| Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
| Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
| Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
| Ergoteles LLC | 37,640 | $126,000 | 0.00% |
| MAI Capital Management | 63,210 | $212,000 | 0.00% |
| RBF Capital, LLC | 14,536 | $49,000 | 0.00% |